The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - Ability Pharma (Inst); AstraZeneca (Inst); BioCad; Clovis Oncology (Inst); GlaxoSmithKline (Inst); Gritstone Bio; Merck Serono (Inst); Merck Serono (Inst); MSD (Inst); Seagen; Tesaro (Inst)
Research Funding - GamaMabs Pharma (Inst); Inivata (Inst); Merus (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Tesaro
 
Consulting or Advisory Role - AstraZeneca; Genmab; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Tesaro

Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma: The GINECO-UTOLA study.
 
Florence Joly
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Pfizer; Roche; Sanofi; Tesaro
Research Funding - Astellas Pharma; Janssen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen; Roche; tesaro
 
Pierre Emmanuel Brachet
Honoraria - AstraZeneca; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Tesaro
 
Sophie Abadie Lacourtoisie
No Relationships to Disclose
 
Bernard Asselain
Honoraria - AstraZeneca; Bristol-Myers Squibb; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Pierre Fabre
 
Anne Floquet
Consulting or Advisory Role - AstraZeneca; CLOVIS ONCOLOGY; GlaxoSmithKline; MSD Oncology; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD Oncology; Roche; Tesaro
 
Olivier Collard
No Relationships to Disclose
 
Manuel Rodrigues
No Relationships to Disclose
 
Karen Leroy
Honoraria - AstraZeneca; Bristol-Myers Squibb; NanoString Technologies; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Corinne Jeanne
No Relationships to Disclose
 
Alexandra Leary
No Relationships to Disclose
 
Sarah Betrian
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; ECS PROGASTRIN; GlaxoSmithKline; LEK; Novartis; Roche/Genentech; TESARO
Research Funding - Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
 
Yolanda Fernandez Diez
No Relationships to Disclose
 
Anne-Claire Hardy-Bessard
No Relationships to Disclose
 
Annick Chevalier
No Relationships to Disclose
 
Elsa Kalbacher
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline/Novartis; LEO Pharma; Sanofi; Tesaro
 
Corina Cornila
No Relationships to Disclose
 
Cyril Foa
No Relationships to Disclose
 
Philippe Follana
Expert Testimony - AstraZeneca; Ipsen; Novartis; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; tesaro
 
Jerome Alexandre
Honoraria - AstraZeneca; GlaxoSmithKline; Ipsen; MSD Oncology; MSD Oncology; Novartis; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - AstraZeneca; Ipsen; Novartis; Roche; Sanofi
Research Funding - Janssen (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Janssen; Novartis